Russell Investments Group Ltd. Invests $672,000 in Nutex Health Inc. (NASDAQ:NUTX)

Russell Investments Group Ltd. bought a new position in Nutex Health Inc. (NASDAQ:NUTX) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 21,195 shares of the company’s stock, valued at approximately $672,000. Russell Investments Group Ltd. owned 0.39% of Nutex Health as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Beaird Harris Wealth Management LLC acquired a new stake in Nutex Health during the 3rd quarter worth $69,000. Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health in the fourth quarter valued at about $206,000. World Investment Advisors bought a new stake in shares of Nutex Health in the fourth quarter valued at about $217,000. State Street Corp acquired a new position in shares of Nutex Health during the third quarter worth about $225,000. Finally, Legato Capital Management LLC grew its holdings in shares of Nutex Health by 26.8% during the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock worth $1,004,000 after buying an additional 6,697 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

Nutex Health Trading Up 0.5 %

Shares of Nutex Health stock opened at $146.00 on Wednesday. The business has a fifty day simple moving average of $74.35 and a two-hundred day simple moving average of $47.82. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The company has a market capitalization of $807.09 million, a price-to-earnings ratio of -15.55 and a beta of 0.27. Nutex Health Inc. has a 1 year low of $4.16 and a 1 year high of $152.51.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $11.21. The firm had revenue of $81.30 million for the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the business’s stock in a transaction on Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the purchase, the chief financial officer now directly owns 4,888 shares of the company’s stock, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 38.52% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Separately, Maxim Group boosted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, April 8th.

Nutex Health Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.